Cyclooxygenase- and lipoxygenase-mediated DNA damage

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer incidence is increasing globally, particularly in aging populations.
• Tumorigenesis involves DNA damage leading to mutations in proto-oncogenes and tumor suppressor genes.
• Cyclooxygenase-2 (COX-2) is upregulated early in tumorigenesis and promotes proliferation via arachidonic acid (AA) metabolites like prostaglandin E(2).

Purpose of the Study:

• To investigate the link between COX-2 activity and DNA damage in cancer.
• To identify specific DNA adducts formed through COX-2-mediated arachidonic acid metabolism.
• To assess the mutagenicity of these DNA adducts and their role in tumorigenesis.

Main Methods:

• Analysis of arachidonic acid (AA) metabolism products in relation to COX-2 activity.
• Identification and characterization of DNA adducts formed by AA metabolites.
• Assessment of the mutagenic potential of identified DNA adducts in mammalian cell lines.

Main Results:

• COX-2-mediated AA metabolism generates heptanone-etheno (Hε)-DNA adducts.
• These Hε-DNA adducts result from the reaction of DNA with 4-oxo-2(E)-nonenal (ONE), a lipid hydroperoxide-derived electrophile.
• 5-lipoxygenase-mediated AA metabolism also produces ONE-derived DNA adducts.
• The identified Hε-DNA adducts are highly mutagenic in mammalian cells.

Conclusions:

• The formation of mutagenic Hε-DNA adducts via COX-2 and 5-lipoxygenase pathways provides a mechanism linking these enzymes to somatic mutations in cancer.
• These findings suggest a significant role for COX-2-mediated DNA damage in the initiation and progression of approximately 80% of cancers arising from somatic mutations.